Modern antidepressants and hallucinations;Moderne antidepressiva en hallucinaties

Tijdschrift voor Psychiatrie

Volumn 56, Issue 6, 2014, Pages 407-412

  Kolthof, Henk Jan ^a  

^a Lucertis   (Netherlands)

Author keywords

Antidepressants; Hallucinations; Side effects

Indexed keywords

ANTIDEPRESSANT AGENT;

AGE DISTRIBUTION; ARTICLE; DATA BASE; DEPRESSION; DRUG SURVEILLANCE PROGRAM; HALLUCINATION; HUMAN; MENTAL DISEASE; NETHERLANDS; SIDE EFFECT; CHEMICALLY INDUCED;

ANTIDEPRESSIVE AGENTS; HALLUCINATIONS; HUMANS; PHARMACOVIGILANCE;

EID: 84903139723     PISSN: 03037339     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Bourgeois JA, Thomas D, Johansen T, Walker DM. Visual hallucinations associated with fluoxetine and sertraline. J Clin Psychopharmacol 1998; 18: 482-3. (Pubitemid 28555333)
2. Bowers MB, McKay BG, Mazure CM. Discontinuation of antidepressants in newly admitted psychotic patients. J Neuropsychiatry Clin Neurosci 2003; 15: 227-30. (Pubitemid 36520344)
3. Bylund DB, Reed AL. Childhood and adolescent depression: why do children and adults respond differently to antidepressant drugs. Neurochem Int 2007; 51: 246-53. (Pubitemid 47374323)
4. Cancelli I, Marcon G, Balestrieri M. Factors associated with complex visual hallucinations during antidepressant treatment. Hum Psychopharmacol Clin Exp 2004; 19: 577-84. (Pubitemid 40028359)
5. Ginsberg DL. Sertraline-induced visual hallucinations. Primary Psychiatry 2004; 11: 13-7.
6. Kumagai R, Ohnuma T, Nagata T, Arai H. Visual and auditory hallucinations with excessive intake of paroxetine. Psychiatry Clin Neurosci 2003; 57: 548-9. (Pubitemid 37247754)
7. Marcon G, Cancelli I, Zamarian L, Bergonzi P, Balestrieri M. Visual hallucinations with sertraline. J Clin Psychiatry 2004; 65: 446-7.
8. Papakostas GI, Charles D, Fava M. Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder. World J Biol Psychiatry 2010; 11: 300-7.
9. Popli AP, Fuller MA, Jaskiw GE. Sertraline and psychotic symptoms: a case series. Ann Clin Psychiatry 1997; 9: 15-7. (Pubitemid 27425015)
10. Preda A, Maclean RW, Mazure CM, Bowers MB. Antidepressant-associated mania and psychosis resulting in psychiatric admissions. J Clin Psychiatry 2001; 62: 30-3. (Pubitemid 32154315)
11. Ruhé HG, Booij J, Weert HC van, Reitsma JB, Fransen EJF, Michel MC, e.a. Evidence why paroxetine dose escalation is not effective in major depressive disorder: a randomized controlled trial with assessment of serotonin transporter occupancy. Neuropsychopharmacology 2009; 34: 999-1010.
12. Schuld A, Archelos JJ, Friess E. Visual hallucinations and psychotic symptoms during treatment with selective serotonin reuptake inhibitors: Is the sigma receptor involved? J Clin Psychopharmacol 2000; 20: 579-80.
13. Stichting Farmaceutische Kengetallen. Gebruikers antidepressiva vooral vrouwen. Pharmaceutisch Weekblad 2011; 146: 44. www.sfk.nl.
14. Stichting Farmaceutische Kengetallen. Gemiddelde groei antidepressivagebruik. Pharmaceutisch Weekblad, 2013; 148: 7. www.sfk.nl.
15. Wilens TE, Biederman J, Kwon A, Chase R, Greenberg L, Mick E, e.a. A systematic chart review of the nature of psychiatric adverse events in children and adolescents treated with selective serotonin reuptake inhibitors. J Child Adol Psychopharmacol 2003; 13: 143-52.